🇺🇸 Taxotere in United States

65,553 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Alopecia — 21,379 reports (32.61%)
  2. Emotional Distress — 6,595 reports (10.06%)
  3. Psychological Trauma — 6,207 reports (9.47%)
  4. Anxiety — 5,920 reports (9.03%)
  5. Pain — 5,160 reports (7.87%)
  6. Madarosis — 4,491 reports (6.85%)
  7. Hair Texture Abnormal — 4,280 reports (6.53%)
  8. Hair Colour Changes — 4,175 reports (6.37%)
  9. Hair Disorder — 4,038 reports (6.16%)
  10. Impaired Quality Of Life — 3,308 reports (5.05%)

Source database →

Taxotere in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United States

Frequently asked questions

Is Taxotere approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Taxotere in United States?

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is the originator. The local marketing authorisation holder may differ — check the official source linked above.